NCT06951022

Brief Summary

This study aims to investigate the effect of Su Jok therapy, a complementary medicine practice, on urinary incontinence and quality of life among postmenopausal women. A total of 120 participants will be included in the study, with 60 in the intervention group and 60 in the control group. Participants in the intervention group will receive Su Jok seed therapy applied to the hand reflex points corresponding to the bladder. The therapy will be administered by the researcher and then taught to the participants, who will continue the application for 15 days. Assessments will be conducted at baseline, day 15, and day 30 using validated questionnaires.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 30, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 11, 2025

Completed
19 days until next milestone

First Posted

Study publicly available on registry

April 30, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2025

Completed
Last Updated

April 30, 2025

Status Verified

April 1, 2025

Enrollment Period

6 months

First QC Date

April 11, 2025

Last Update Submit

April 22, 2025

Conditions

Keywords

Su Jok TherapyUrinary IncontinenceQuality of LifePostmenopausal Women

Outcome Measures

Primary Outcomes (2)

  • Change in urinary incontinence symptoms measured by the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF)

    Description: The ICIQ-SF is a 4-item questionnaire used to evaluate the severity and impact of urinary incontinence. Scoring: Scores range from 0 to 21, with higher scores indicating more severe urinary incontinence. Unit of Measure: Points on a scale

    At baseline, 15 days and 30 days after intervention

  • Change in quality of life measured by the Incontinence Quality of Life Scale (I-QOL)

    Description: The I-QOL assesses quality of life, including behavioral limitation, psychosocial impact, and social isolation, in postmenopausal women with urinary incontinence. Scoring: Domain scores range from 0 to 100, where higher scores represent a poorer quality of life. Unit of Measure: Total score (0-100)

    At baseline, 15 days and 30 days after intervention

Study Arms (2)

Intervention

EXPERIMENTAL

Participants in the intervention group will receive seed therapy using apple seeds applied to specific hand points corresponding to the bladder area.

Other: Sujok therapy

Control

NO INTERVENTION

standard care

Interventions

Participants in the intervention group will receive seed therapy using apple seeds applied to specific hand points corresponding to the bladder area.

Intervention

Eligibility Criteria

AgeUp to 65 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailspostmenopausal women
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Women under 65 years of age in the postmenopausal period, Literate, No speech or communication impairment

You may not qualify if:

  • Use of diuretics
  • Presence of nephrotic syndrome
  • Diagnosis of diabetes or hypertension
  • Symptoms of urinary tract infection
  • Diagnosis of psychiatric illness
  • History of urinary tract surgery
  • Diagnosed urinary prolapse
  • Failure to complete the intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Inonu University

Battalgazi, Malatya, 44280, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Urinary Incontinence

Condition Hierarchy (Ancestors)

Urination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants in the experimental group will receive Su Jok seed therapy using apple seeds applied to the hand point that reflects the bladder. Participants will be trained to perform the therapy themselves and will apply it daily for 15 days. They will be reminded via daily messages and monitored for adherence.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Principal Investigator

Study Record Dates

First Submitted

April 11, 2025

First Posted

April 30, 2025

Study Start

January 30, 2025

Primary Completion

July 30, 2025

Study Completion

July 30, 2025

Last Updated

April 30, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL

Locations